135 related articles for article (PubMed ID: 38606724)
1. Impact of time to start of tranexamic acid treatment on rebleed risk and outcome in aneurysmal subarachnoid hemorrhage.
Germans MR; Tjerkstra MA; Post R; Brenner A; Vergouwen MD; Rinkel GJ; Roos YB; van den Berg R; Coert BA; Vandertop WP; Verbaan D;
Eur Stroke J; 2024 Apr; ():23969873241246591. PubMed ID: 38606724
[TBL] [Abstract][Full Text] [Related]
2. Ultra-Early and Short-Term Tranexamic Acid Treatment in Patients With Good- and Poor-Grade Aneurysmal Subarachnoid Hemorrhage.
Tjerkstra MA; Post R; Germans MR; Vergouwen MDI; Jellema K; Koot RW; Kruyt ND; Wolfs JFC; De Beer FC; Kieft HH; Nanda D; Van Der Pol B; Roks G; De Beer F; Reichman LJA; Brouwers PJAM; Kwa VIH; Van Der Ree TC; Bienfait HP; Boogaarts HD; Klijn CJ; Visser V; van den Berg R; Coert BA; Horn J; Majoie CBLM; Rinkel GJE; Roos YBWEM; Vandertop WP; Verbaan D;
Neurology; 2024 Jun; 102(12):e209169. PubMed ID: 38788175
[TBL] [Abstract][Full Text] [Related]
3. Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan.
Post R; Germans MR; Coert BA; Rinkel GJE; Vandertop WP; Verbaan D
Trials; 2020 Feb; 21(1):199. PubMed ID: 32070395
[TBL] [Abstract][Full Text] [Related]
4. Effects of Tranexamic Acid in Patients with Subarachnoid Hemorrhage in Brazil: A Prospective Observational Study with Propensity Score Analysis.
Rynkowski CB; Hegele V; Soares PHR; Tonello ML; Petterson L; Gomes FK; Rabinstein AA; Bastos LSL; Turon R; Gonçalves B; Righy C; Bozza FA; Kurtz P
Neurocrit Care; 2023 Aug; 39(1):191-197. PubMed ID: 37131089
[TBL] [Abstract][Full Text] [Related]
5. Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial.
Germans MR; Post R; Coert BA; Rinkel GJ; Vandertop WP; Verbaan D
Trials; 2013 May; 14():143. PubMed ID: 23680226
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage: Post Hoc Analysis of the ULTRA Trial.
Tjerkstra MA; Post R; Germans MR; Vergouwen MDI; Jellema K; Koot RW; Kruyt ND; Willems PWA; Wolfs JFC; de Beer FC; Kieft H; Nanda D; van der Pol B; Roks G; de Beer F; Halkes PHA; Reichman LJA; Brouwers PJAM; Van den Berg-Vos RM; Kwa VIH; van der Ree TC; Bronner I; Bienfait HP; Boogaarts H; Klijn CJM; van den Berg R; Coert BA; Horn J; Majoie CBLM; Rinkel GJE; Roos YBWM; Vandertop WP; Verbaan D;
Neurology; 2022 Dec; 99(23):e2605-e2614. PubMed ID: 36266046
[TBL] [Abstract][Full Text] [Related]
7. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.
Hillman J; Fridriksson S; Nilsson O; Yu Z; Saveland H; Jakobsson KE
J Neurosurg; 2002 Oct; 97(4):771-8. PubMed ID: 12405362
[TBL] [Abstract][Full Text] [Related]
8. Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial.
Post R; Germans MR; Tjerkstra MA; Vergouwen MDI; Jellema K; Koot RW; Kruyt ND; Willems PWA; Wolfs JFC; de Beer FC; Kieft H; Nanda D; van der Pol B; Roks G; de Beer F; Halkes PHA; Reichman LJA; Brouwers PJAM; van den Berg-Vos RM; Kwa VIH; van der Ree TC; Bronner I; van de Vlekkert J; Bienfait HP; Boogaarts HD; Klijn CJM; van den Berg R; Coert BA; Horn J; Majoie CBLM; Rinkel GJE; Roos YBWEM; Vandertop WP; Verbaan D;
Lancet; 2021 Jan; 397(10269):112-118. PubMed ID: 33357465
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials.
Ren J; Qian D; Wu J; Ni L; Qian W; Zhao G; Huang C; Liu X; Zou Y; Xing W
Front Neurol; 2021; 12():710495. PubMed ID: 35140671
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid for patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of 2991 patients.
Ghaith HS; Gabra MD; Ebada MA; Dada OE; Al-Shami H; Bahbah EI; Swed S; Ghaith AK; Kanmounye US; Esene IN; Negida A
Int J Neurosci; 2024 Jul; 134(7):763-776. PubMed ID: 36463556
[TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
Germans MR; Dronkers WJ; Baharoglu MI; Post R; Verbaan D; Rinkel GJ; Roos YB
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001245. PubMed ID: 36350005
[TBL] [Abstract][Full Text] [Related]
12. Commentary on Post,
Lo BWY; Fukuda H; Tsang ACO; Langer DJ; Miyawaki S; Koyanagi M; Lui MW
Surg Neurol Int; 2021; 12():156. PubMed ID: 33948326
[TBL] [Abstract][Full Text] [Related]
13. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
[TBL] [Abstract][Full Text] [Related]
14. Antifibrinolytic drugs for treating primary postpartum haemorrhage.
Shakur H; Beaumont D; Pavord S; Gayet-Ageron A; Ker K; Mousa HA
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012964. PubMed ID: 29462500
[TBL] [Abstract][Full Text] [Related]
15. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
Baharoglu MI; Germans MR; Rinkel GJ; Algra A; Vermeulen M; van Gijn J; Roos YB
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD001245. PubMed ID: 23990381
[TBL] [Abstract][Full Text] [Related]
16. Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage.
Lindgren A; Vergouwen MD; van der Schaaf I; Algra A; Wermer M; Clarke MJ; Rinkel GJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD003085. PubMed ID: 30110521
[TBL] [Abstract][Full Text] [Related]
17. Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding.
Ruigrok YM; Slooter AJ; Rinkel GJ; Wijmenga C; Rosendaal FR
Acta Neurochir (Wien); 2010 Feb; 152(2):257-62. PubMed ID: 19826759
[TBL] [Abstract][Full Text] [Related]
18. Effect of short-term ε-aminocaproic acid treatment on patients undergoing endovascular coil embolization following aneurysmal subarachnoid hemorrhage.
Malekpour M; Kulwin C; Bohnstedt BN; Radmand G; Sethia R; Mendenhall SK; Weyhenmeyer J; Hendricks BK; Leipzig T; Payner TD; Shah MV; Scott J; DeNardo A; Sahlein D; Cohen-Gadol AA
J Neurosurg; 2017 May; 126(5):1606-1613. PubMed ID: 27315025
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Shi M; Yang C; Chen ZH; Xiao LF; Zhao WY
Front Surg; 2021; 8():790149. PubMed ID: 35083272
[TBL] [Abstract][Full Text] [Related]
20. Twenty-four-hour emergency intervention versus early intervention in aneurysmal subarachnoid hemorrhage.
Linzey JR; Williamson C; Rajajee V; Sheehan K; Thompson BG; Pandey AS
J Neurosurg; 2018 May; 128(5):1297-1303. PubMed ID: 28731402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
